No abstract available.
Angina Pectoris* ; Electrocardiography* ; Pheochromocytoma*

24 deaths of myocardiac infarction in 140 patients with the myocardial infarction in the Institute of Cardiovascular were studied. The results have shown that the male mortality rate: 60,87%. The ages of patient were direct proportional with the mortality rate. The death within the first 24 hours accounts for 69,56%. The major causes were cardiac shock and arrhythmias- the common risks were hypertension, history of angina pectoris and diabetes. The deaths due to the myocardial infarction with penetration of the wall were 95,66%. The subendometrial myocardial infarction: 4,3%.
Myocardial Infarction ; Angina Pectoris

Angina Pectoris* ; Diagnosis*

Study on 154 patients with chest pain, mean age: 61 years old, males accounted for 65%. Most common risk factors were hypertension 74%, high serum cholesterol level 60.4%, smoking 47.4%, diabetes 19.5%, family history 30.5%. B-mode ultrasonographic findings were normal carotid arteries in 22 patients (14.3%), intima-media thickness (IMT) >0.7 mm in 132 patients (85.7%), plaques of unilateral carotid arteries in 77 patients (50%), and plaques of bilateral carotid arteries in 36 patients (23.4%). There was a correlation between the IMT, the plaques of carotid arteries and the ages
Atherosclerosis, chest pain, angina pectoris

An open trial was carried out to investigate the efficacy and tolerance of isosorbide 5-mononitrate(Elantan(R)) in 30 patients diagnosed as angina pectoris at Pusan national university hospital. Drugs were given 20mg two times daily for 2 to 3 weeks and the results were assessed in terms of effects on anginal pain and untoward side effects experienced during administration of medication. Treament resulted in an overall improvement in 25 patients(83.4%), complete abolition of anginal attacks in 17 patients(56.7%) and reduction in frequency of attacks in 8 patients(26.7%). So called "Nitrated headache" was observed in 5 patients(16.6%) but improved with proceeding of administration in 3 patients. This trial indicates that isosorbide 5-mononitrate should be efficacious as well as tolerated in patients with coronary heart disease.
Angina Pectoris* ; Busan ; Coronary Disease ; Humans ; Isosorbide*

OBJECTIVETo compare clinical effects of acupuncture combined with medication and simple medication on intractable angina pectoris (IAP).

METHODSSeventy cases of IAP were randomly divided into two groups, a control group and a treatment group, 35 cases in each group. The control group were treated with nitric acid ester, beta-receptor blocking agent, calcium antagonist, aspirin and hypo-molecular heparin, and the treatment group were treated with acupuncture at Danzhong (CV 17) and Neiguan (PC 6) and others, once daily for 10 consecutive days on the basis of the above treatment.

RESULTSThe total effective rates for symptoms and electrocardiogram were 88.6% and 62.9% in the treatment group and 60.0% and 31.4% in the control group, respectively, with a significant difference between the two groups; the incidence of acute heart attack and sudden death of 5.7% in the treatment group was lower than 20.0% in the control group, with no serious adverse effect.

CONCLUSIONAcupuncture combined with medication is safe and effective for intractable angina pectoris and it can improve short-term prognosis.

To substantiate the hypothesis that patients with antecedent angina(> or =24hr before myocardial infarcton) are more likely to have a significant residual stenosis than are those without antedecent angina, the coronary angiogram of 27 patients with successful coronary thrombolysis for acute myocardial infarction were reviewed. In comparison with the patients without antecedent angina the patient with antecedent angina had an increased mean stenosis (86.9% vs 69.3%) and had a more decreased ejection fraction(52.3% vs 65.6%). These findings suggest that angina pectoris before acute myocardial infarction would be regarded as one of high risk factors after acute myocardial infarction.
Angina Pectoris* ; Constriction, Pathologic* ; Humans ; Myocardial Infarction* ; Risk Factors

A double-blind trial of the efficacy of propranolol hydrochloride a new beta adrenergic blocking agent, in the prophylactic treatment of angina pectoris was conducted in 9 patients. Through the trial period of 8 weeks to more than 26 weeks, the patients received propranolol and placebo for equal period. Following are the results. 1. The effective dose of propranolol hydrochloride in the prophylactic treatment of angina pectoris was 80 mg to 120 mg per day. 2. The effectiveness of propranolol hydrochloride was manifested by a reduction in frequency of pain to 40.7%, in nitroglycerin comsumption to 38.8% and by an increase in exercise tolerance. 3. Obseved side effects were transient nausea, vomiting and bradycardia, which were improved with reduction in drug dosage. 4. Further clinical and experimental information may be necessary in order to assess the long-term effects of propranolol hydrochloride.
Angina Pectoris* ; Bradycardia ; Exercise Tolerance ; Humans ; Nausea ; Nitroglycerin ; Propranolol* ; Vomiting

A clinical study on the antihypertensive effect of long-acting propranolol was performed in 25 patients with essential hypertension. Following a week treatment of the subjects with the regimen of propranolol 40mg twice a day during the first week, 160mg of long-acting propranolol was given once a day for the subsequent 4 weeks. At the end of the fifth week, in 8 out of 25(32%) blood pressures were lowered to the level of 140/90 mmHg or lower, in another 8(32%) the blood pressures were lowered by 20 mmHg or more of systolic and/or 10mmhg or more of the diastolic pressures. Eleven out of 12 subjects, whose blood pressures had been significantly lowered at the end of the first week of propranolol treatment, manifested significant blood pressure lowerings also at the end of 4 weeks' long-acting propranolol treatments. Long-acting propranolol had beneficial effect of ameliorating anginal pain in 2 subjects who had had angina pectoris before the beginning of hypertension. Adverse side eiffects observed were mild fatigue in one, indigestion in one and sinus bradycardia in another one.
Angina Pectoris ; Blood Pressure ; Bradycardia ; Dyspepsia ; Fatigue ; Humans ; Hypertension ; Propranolol

Angina Pectoris ; complications ; Cardiomyopathies ; complications ; pathology ; Female ; Humans ; Middle Aged